The Costa Rican News (TCRN) – Costa Rica is headed for legislative approval of a bill that restores biomedical research, after the Constitutional Court gave the green light, which has led to the satisfaction of the scientific and governmental sector.
“We are very pleased with the decision of the Board, which is blunt and removes any doubt about the legality and constitutionality of the research in the country,” said the president of the Costa Rican Institute of Clinical Research (ICIC), Guillermo Rodríguez.
For scientists, the Biomedical Research Act is a need for Costa Rica as they do not want it to be the only country in the world where they can’t investigate these issues.
The Constitutional Court ruled on Thursday that there are no constitutional problems in the bill that regulates these investigations, after considering numerous inquiries made by legislative members and other citizens.
The project was approved by Congress in the first debate last November, and the ruling of the Constitutional Court is the open road for the second and final vote, possibly next week.
It was the same room that banned such research before because of weak controls and regulations.
According to Rodriguez, the prior decision of the court has caused Costa Rica to suffer loss of leadership at the country-level clinical research level and that the big losers are the patients who lost the opportunity to access effective treatment.
He added that about 20 research centers were closed, nearly 200 people lost their jobs and there was benefit to other countries in the region who now pose serious competition in the subject.
Meanwhile, Costa Rican President Laura Chinchilla tersely told reporters that the government is “very pleased” with the ruling of the Constitutional Court and expects Congress to pass the law soon.
The Costa Rican government supports the bill because it believes that it will enhance the scientific and business growth in the country while promoting health.
Opponents of the project have pointed out that the law does not have sufficient controls on tests and contains ethical lapses.
ICIC data indicates that before the ban in Costa Rica there were 200 clinical investigations which resulted in the creation of 25 drugs to treat diseases such as asthma, hypertension, cancer, diabetes and HIV. (ACAN-EFE)
The Costa Rican News (TCRN)
San Jose, Costa Rica